Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Erlotinib loaded pegylated polypeptide lipid nanocapsules to enhance the anticancer efficacy in non-small cell lung cancer

  • In: Poster presentation
  • At: Seoul (South Korea) (2017)
  • Type: Poster
  • Poster code: POS-FDP-016
  • By: KIM, Jong Oh (Yeungnam University, Gyeongsan-si, Korea, Republic Of)
  • Co-author(s): Jae Hee Kim: Yeungnam University, Gyeongsan-si, Korea, Republic Of
    Jun Ho Son: Yeungnam University, Gyeongsan-si, Korea, Republic Of
    Myung-Ja Hong: Yeungnam University, Gyeongsan-si, Korea, Republic Of
    Young-Im Lee: Yeungnam University, Gyeongsan-si, Korea, Republic Of
    Dong Shik Kim: Hanyang University, Ansan-si, Korea, Republic Of
    Han-Gon Choi: Hanyang University, Ansan-si, Korea, Republic Of
    Chul Soon Yong: Yeungnam University, Gyeongsan-si, Korea, Republic Of
    Jong Oh Kim: Yeungnam University, Gyeongsan-si, Korea, Republic Of
  • Abstract:

    Background

    Lung cancer is the leading cause of cancer-related death worldwide. ERL blocks the kinase activity by selectively binding to the ATP-binding site of EGFR. The oral delivery of ERL is accompanied by severe side effects including rash, diarrhea, gastrointestinal (GI) perforations, ocular lesions, and hematological disorders. Therefore,..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses